Varying effects of temperature, Ca(2+) and cytochalasin on fusion activity mediated by human immunodeficiency virus type 1 and type 2 glycoproteins

FEBS Lett. 2000 Jun 2;474(2-3):246-51. doi: 10.1016/s0014-5793(00)01600-8.

Abstract

We examined fusion mediated by the human immunodeficiency virus type 1 (HIV-1) and type 2 (HIV-2) envelope glycoproteins under various experimental conditions. Incubation of HeLa cells expressing HIV-2(ROD) and HIV-2(SBL/ISY) envelope glycoproteins with HeLa-CD4 target cells resulted in fusion at temperatures >/=25 degrees C whereas fusion with cells expressing HIV-1(Lai) occurred only at >/=31 degrees C. HIV-2 envelope glycoprotein-mediated fusion proceeded in the absence of Ca(2+) in the culture medium, whereas HIV-1 fusion required Ca(2+) ions for fusion. In contrast to HIV-2 envelope glycoprotein fusion, incubations in the presence of the 0.5 microM cytochalasin B completely inhibited HIV-1 envelope glycoprotein-mediated fusion. Our results suggest that in contrast to HIV-2, HIV-1 fusion is dependent on dynamic processes in the target membrane.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Actins / metabolism
  • Biopolymers / metabolism
  • CD4 Antigens / metabolism
  • Calcium / pharmacology*
  • Cell Fusion / drug effects
  • Cytochalasin B / pharmacology*
  • Cytoskeleton / drug effects
  • Cytoskeleton / metabolism
  • Gene Products, env / metabolism*
  • Giant Cells / cytology
  • Giant Cells / drug effects
  • Giant Cells / metabolism
  • Giant Cells / virology
  • HIV-1 / classification
  • HIV-1 / drug effects
  • HIV-1 / physiology*
  • HIV-2 / classification
  • HIV-2 / drug effects
  • HIV-2 / physiology*
  • HeLa Cells
  • Humans
  • Temperature
  • Time Factors

Substances

  • Actins
  • Biopolymers
  • CD4 Antigens
  • Gene Products, env
  • Cytochalasin B
  • Calcium